iwCAR-T Session I: Emerging CARs and future challenges in solid tumors

  Experts Julian Molina (Mayo Clinic, Rochester, MN), Mathew Angelos (University of Pennsylvania, Philadelphia, PA), and Sebastian Kobold (Ludwig-Maximilians-University of Munich, Munich, Germany) bring you updates live from the International Workshop of CAR-T and Immunotherapies (iwCART) 2023. In considering the latest research and trials in the field of CAR T-cell therapy and the challenges associated with treating solid tumors, these specialists discuss using CAR macrophages in combination with other immunotherapies, manipulating the tumor microenvironment, the genetic engineering of CAR T-cells to add and/or remove specific factors and tumor heterogeneity.